×
Supernus Pharmaceuticals Inventory 2011-2024 | SUPN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Supernus Pharmaceuticals inventory from 2011 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Supernus Pharmaceuticals Inventory 2011-2024 | SUPN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Supernus Pharmaceuticals inventory from 2011 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.2B
BridgeBio Pharma (BBIO)
$6.9B
Bausch Health Cos (BHC)
$2.4B
Amphastar Pharmaceuticals (AMPH)
$1.5B
Personalis (PSNL)
$412M
Taysha Gene Therapies (TSHA)
$336M
Assembly Biosciences (ASMB)
$81M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$8M
Teligent (TLGT)
$0M